Wealth Quarterback LLC Fennec Pharmaceuticals Inc. Transaction History

Wealth Quarterback LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$5.17 - $6.33 $5,170 - $6,330	-1,000 Closed	0 $0
Q2 2021 Aug 11, 2021	BUY	$5.96 - $7.85 $5,960 - $7,850	1,000 New	1,000 $8,000
Q2 2020 Aug 17, 2020	SELL	$5.43 - $9.39 $5,430 - $9,390	-1,000 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$4.89 - $8.1 $26,308 - $43,578	-5,380 Reduced 84.33%	1,000 $0
Q4 2019 Feb 27, 2020	BUY	$4.25 - $6.49 $27,115 - $41,406	6,380 New	6,380 $0

14.7M

10K

83.8K

Ticker FENC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,067,300
Market Cap $165M
Description
Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...

Get notified when there are updates to the investment portfolio of Wealth Quarterback LLC, based on Form 13F filings with the SEC.

Stay updated on Wealth Quarterback LLC with notifications on news.